Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha
- PMID: 8145033
- PMCID: PMC2191432
- DOI: 10.1084/jem.179.4.1109 (VSports在线直播)
Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha (VSports在线直播)
Abstract
Using granulocyte/macrophage colony-stimulating factor (GM-CSF) and interleukin 4 we have established dendritic cell (DC) lines from blood mononuclear cells that maintain the antigen capturing and processing capacity characteristic of immature dendritic cells in vivo. These cells have typical dendritic morphology, express high levels of major histocompatibility complex (MHC) class I and class II molecules, CD1, Fc gamma RII, CD40, B7, CD44, and ICAM-1, and lack CD14. Cultured DCs are highly stimulatory in mixed leukocyte reaction (MLR) and are also capable of triggering cord blood naive T cells. Most strikingly, these DCs are as efficient as antigen-specific B cells in presenting tetanus toxoid (TT) to specific T cell clones. Their efficiency of antigen presentation can be further enhanced by specific antibodies via FcR-mediated antigen uptake. Incubation of these cultured DCs with tumor necrosis factor alpha (TNF-alpha) or soluble CD40 ligand (CD40L) for 24 h results in an increased surface expression of MHC class I and class II molecules, B7, and ICAM-1 and in the appearance of the CD44 exon 9 splice variant (CD44-v9); by contrast, Fc gamma RII is markedly and sometimes completely downregulated VSports手机版. The functional consequences of the short contact with TNF-alpha are in increased T cell stimulatory capacity in MLR, but a 10-fold decrease in presentation of soluble TT and a 100-fold decrease in presentation of TT-immunoglobulin G complexes. .
References
-
- Proc Natl Acad Sci U S A. 1990 Oct;87(19):7698-702 - PubMed
-
- J Immunol. 1990 Nov 1;145(9):2820-6 - PubMed
-
- Nature. 1990 Nov 8;348(6297):163-6 - PubMed
-
- Eur J Immunol. 1990 Nov;20(11):2367-73 - "V体育安卓版" PubMed
-
- Immunol Rev. 1990 Oct;117:213-34 - PubMed
Publication types
MeSH terms
- Actions (V体育官网入口)
- Actions (V体育2025版)
- V体育安卓版 - Actions
- Actions (VSports在线直播)
- V体育安卓版 - Actions
- V体育官网 - Actions
Substances
- "V体育官网" Actions
- "VSports" Actions
LinkOut - more resources (V体育官网入口)
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous